CS
VERA icon

Candriam SCA’s Vera Therapeutics VERA Stock Holding History

Candriam SCA’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.1M Sell
468,099
-7,236
-2% -$270K 0.09% 201
2026
Q1 		$19.1M Buy
475,335
+25,781
+6% +$1.11M 0.1% 201
2025
Q4 		$22.8M Buy
449,554
+22,365
+5% +$794K 0.11% 176
2025
Q3 		$12.4M Buy
427,189
+130,248
+44% +$3.01M 0.07% 243
2025
Q2 		$7M Sell
296,941
-66,751
-18% -$1.5M 0.04% 304
2025
Q1 		$8.74M Sell
363,692
-2,307
-0.6% -$74.1K 0.05% 258
2024
Q4 		$15.5M Sell
365,999
-84,993
-19% -$3.76M 0.09% 202
2024
Q3 		$19.9M Buy
450,992
+157,232
+54% +$5.97M 0.11% 180
2024
Q2 		$10.6M Buy
293,760
+185,760
+172% +$7.37M 0.06% 246
2024
Q1 		$4.66M Buy
+108,000
New +$3.85M 0.03% 354

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Candriam SCA's VERA Position: Q2 2026 in Review

Candriam SCA reduced its Vera Therapeutics (VERA) stake by 1.5% in Q2 2026, selling an estimated $270K and leaving 468,099 shares worth $20.1M. The position accounts for 0.09% of the portfolio, ranked #201.

Candriam SCA first reported a position in VERA in Q1 2024 and has held it in 10 quarters since. The position peaked at $22.8M in Q4 2025. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Candriam SCA held 468,099 shares of Vera Therapeutics worth $20.1M as of Q2 2026.
  • Candriam SCA sold 7,236 Vera Therapeutics shares in Q2 2026, an estimated $270K.
  • Vera Therapeutics made up 0.09% of Candriam SCA's portfolio in Q2 2026, its #201 holding.
  • Candriam SCA first reported a position in Vera Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Candriam SCA's Vera Therapeutics position peaked at $22.8M in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.